Healthcare provider profile · identity verified

Connie M Walker, P.A.-C.

Physician Assistant · SEQUIM, WA · NPI 1407871718

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	586	156
Levothyroxine Sodium	Levothyroxine Sodium	396	103
Lisinopril	Lisinopril	312	88
Losartan Potassium	Losartan Potassium	304	87
Gabapentin	Gabapentin	272	75
Amlodipine Besylate	Amlodipine Besylate	259	68
Omeprazole	Omeprazole	241	70
Metoprolol Succinate	Metoprolol Succinate	229	69
Hydrochlorothiazide	Hydrochlorothiazide	207	58
Rosuvastatin Calcium	Rosuvastatin Calcium	149	44
Sertraline Hcl	Sertraline Hcl	143	33
Metformin Hcl Er	Metformin Hcl	124	34
Eliquis	Apixaban	121	34
Potassium Chloride	Potassium Chloride	118	37
Furosemide	Furosemide	109	33
Trazodone Hcl	Trazodone Hcl	106	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	20
Simvastatin	Simvastatin	101	27
Telmisartan	Telmisartan	90	28
Metformin Hcl	Metformin Hcl	89	25
Alendronate Sodium	Alendronate Sodium	87	26
Tamsulosin Hcl	Tamsulosin Hcl	86	26
Albuterol Sulfate Hfa	Albuterol Sulfate	82	33
Jardiance	Empagliflozin	78	20
Duloxetine Hcl	Duloxetine Hcl	75	19
Fluoxetine Hcl	Fluoxetine Hcl	74	22
Buspirone Hcl	Buspirone Hcl	71	19
Prednisone	Prednisone	69	36
Spironolactone	Spironolactone	67	18
Pantoprazole Sodium	Pantoprazole Sodium	66	15
Citalopram Hbr	Citalopram Hydrobromide	65	18
Ozempic	Semaglutide	64	suppressed
Carvedilol	Carvedilol	62	14
Atenolol	Atenolol	60	17
Clopidogrel	Clopidogrel Bisulfate	58	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	14
Allopurinol	Allopurinol	55	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	13
Trulicity	Dulaglutide	52	suppressed
Lorazepam	Lorazepam	51	21
Oxycodone Hcl	Oxycodone Hcl	51	16
Metoprolol Tartrate	Metoprolol Tartrate	50	16
Bupropion Xl	Bupropion Hcl	49	16
Paroxetine Hcl	Paroxetine Hcl	49	12
Montelukast Sodium	Montelukast Sodium	48	18
Estradiol	Estradiol	46	22
Tramadol Hcl	Tramadol Hcl	45	18
Fluticasone Propionate	Fluticasone Propionate	44	16
Finasteride	Finasteride	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	14
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	12
Zolpidem Tartrate	Zolpidem Tartrate	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Methocarbamol	Methocarbamol	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Meloxicam	Meloxicam	32	15
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	23
Valsartan	Valsartan	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Baclofen	Baclofen	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Naltrexone Hcl	Naltrexone Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Nystatin	Nystatin	21	13
Acyclovir	Acyclovir	20	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Famotidine	Famotidine	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Azithromycin	Azithromycin	18	18
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Cephalexin	Cephalexin	17	16
Chlorthalidone	Chlorthalidone	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Amoxicillin	Amoxicillin	16	15
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ondansetron Odt	Ondansetron	15	11
Torsemide	Torsemide	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Phenytek	Phenytoin Sodium Extended	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Triazolam	Triazolam	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error